Ingevity Q2 adjusted EPS beats estimates; annual outlook raised
Ingevity Q2 adjusted EPS beats estimates; annual outlook raised
Overview
US specialty materials firm's Q2 adjusted EPS from continuing operations beat analyst expectations
Q2 net sales fell 5% yr/yr, mainly due to Road Markings divestiture
Company completed sale of Road Markings product line and raised full-year adjusted EBITDA outlook
Outlook
Ingevity raises full-year 2026 net sales outlook to $1.05 bln-$1.15 bln
Company sees 2026 adjusted EBITDA between $380 mln and $400 mln
Ingevity expects 2026 diluted adjusted EPS of $5.00-$5.45
Result Drivers
ROAD MARKINGS DIVESTITURE - Net sales fell 5% yr/yr, mainly due to the sale of the Road Markings product line in April
SEGMENT GROWTH - Excluding Road Markings, sales rose 5% with growth across all three segments, driven by higher volumes, favorable mix, and pricing actions
ADVANCED POLYMER TECHNOLOGIES - Segment benefited from higher prices, favorable mix toward higher-value products, and competitor supply disruptions
Company press release: ID:nBw1lfhgza
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Net Sales From Contops | Slight Beat* | $314.10 mln | $312.20 mln (2 Analysts) |
Q2 Adjusted EPS From Contops | Beat | $1.74 | $1.33 (3 Analysts) |
Q2 Net Income From Contops |
| $39.80 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy"
Wall Street's median 12-month price target for Ingevity Corp is $90.00, about 27.4% above its July 29 closing price of $70.62
The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago
Reuters Recommended Reads
July 29 - Stepan Q2 net sales rise on surfactant, polymer growth; to cut jobs
July 29 - FMC Q2 adjusted EPS beats estimates, cuts FY outlook
July 28 - Xylem raises annual profit forecast as AI growth lifts demand for water-treatment equipment
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ingevity
See all newsIngevity Corp reports results for the quarter ended June 30 - Earnings Summary
Ingevity Q2 adjusted EPS beats estimates; annual outlook raised
Ingevity Q1 sales rise driven by Performance Materials segment growth
Brief: Ingevity Q1 EPS USD 1.66
PPG rises to over 1-month high after preliminary Q1 earnings beat